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Summary
The continuous monolayer of intestinal epithelial cells
(IECs) lining the gut lumen functions as the site of nutrient
absorption and as a physical barrier to prevent the transloca-
tion of microbes and associated toxic compounds into the
peripheral vasculature [1]. IECs also express host defense
proteins such as intestinal alkaline phosphatase (IAP),
which detoxify bacterial products and prevent intestinal
inflammation [2–5]. Our laboratory recently showed that
IAP is enriched on vesicles that are released from the tips
of IEC microvilli and accumulate in the intestinal lumen
[6, 7]. Here, we show that these native ‘‘lumenal vesicles’’
(LVs) (1) contain catalytically active IAP that can dephos-
phorylate lipopolysaccharide (LPS), (2) cluster on the
surface of native lumenal bacteria, (3) prevent the adherence
of enteropathogenic E. coli (EPEC) to epithelial monolayers,
and (4) limit bacterial population growth. We also find that
IECs upregulate LV production in response to EPEC and
other Gram-negative pathogens. Together, these results
suggest that microvillar vesicle shedding represents a novel
mechanism for distributing host defense machinery into the
intestinal lumen and that microvillus-derived LVs modulate
epithelial-microbial interactions.
Results and Discussion
A defining feature of the intestinal epithelial cell (IEC) apical
domain is the array of microvilli known as the brush border,
which extends into the intestinal lumen [1]. Within the micro-
villus, the apical membrane and underlying core actin bundle
are linked by myosin-1a (Myo1a), a membrane-binding actin-
based motor [8, 9]. Our previous studies suggest that Myo1a
applies force to the apical membrane, leading to the accumu-
lation of membrane at microvillar tips and ‘‘shedding’’ of
vesicles into the lumen [6, 7]. In mice lacking Myo1a, lumenal
vesicles (LVs) are reduced in number and exhibit perturbations
in morphology and composition [7]. Proteomic studies
revealed that native LVs are enriched in intestinal alkaline
phosphatase (IAP) [7], a host defense factor that reduces the
toxicity of lipopolysaccharide (LPS) and other bacterial
compounds, limits toll-like receptor-4 (TLR4) signaling, and
prevents mucosal inflammation [2–5, 10]. The absence of IAP
also leads to alterations in gut microbiota [11]. Thus, IAP plays
a critical role in preventing mucosal inflammation and main-
taining gut homeostasis.*Correspondence: matthew.tyska@vanderbilt.eduLV-Associated IAP Dephosphorylates LPS
Given the evidence implicating IAP in gut host defense and
homeostasis [2–5, 10, 11], we hypothesized that IAP-enriched
LVs produced by microvilli regulate epithelial-microbial inter-
actions. To test this proposal, we first sought to determine
whether LVs could dephosphorylate the proinflammatory
bacterial product, LPS. Dephosphorylation of LPS reduces
the ability of this compound to activate TLR4 on host cell
membranes [2, 10]. Our laboratory previously developed
methods for isolating native microvillus-derived LVs from
rodent small intestine [7]. Native vesicles isolated with these
methods are able to dephosphorylate LPS from Escherichia
coli serotype O55:B5 in a concentration-dependent manner,
which was sensitive to the IAP inhibitor, L-phenylalanine
(L-phe) (Figure 1A) [12]. This activity was not specific to
E. coli O55:B5 LPS because assays with other LPS variants
also gave rise to robust phosphate release (Figure 1B, black
bars). Purified IAP added at equivalent units of activity (0.1 U
IAP = 10 mg LV, data not shown) demonstrated a comparable
response (Figure 1B, gray bars). Kinetic analysis of phosphate
release from P. aeruginosa and E. coli LPS (substrates that
supported the highest and lowest activities, respectively)
revealed that P. aeruginosa LPS gives rise to higher rates of
phosphate release at lower substrate concentrations (i.e.,
exhibits a lower KM; see Figure S1 available online). Thus,
LV-associated IAP is catalytically active and can dephosphor-
ylate LPS from a variety of Gram-negative species.
LVs Physically Interact with Lumenal Microbes
Because LVs are able to chemically modify bacterial com-
pounds (Figures 1A and 1B; Figure S1), we next sought to
determine whether these vesicles could interact directly with
lumenal microbes. To address this question, we examined
resuspended pellets produced during native LV preparations
from rat intestinal lumen wash using negative stain transmis-
sion electron microscopy (TEM). The resulting images
revealed rod-shaped bacteria coated or in contact with
clusters of material that resembled small vesicles (Figure 1C).
We labeled the same fraction with an anti-IAP antibody,
amembrane dye (DiD), andDAPI (to label bacteria) and imaged
samples using confocal microscopy (CM). Consistent with
the presence of microvillus-derived LVs, we found that
microbe-associated material was highly enriched in IAP and
DiD (Figure 1D).
To analyze minimally processed lumen washmaterial for the
presenceof LV/microbe complexes,wealso employed amodi-
fied form of fluorescence-activated vesicle sorting (FAVS)
[7, 13]. Raw lumen wash from rat small intestine was allowed
to settle at 1 3 g and then passed through a 40 mm filter to re-
move large particulatematter. Samples were then labeled as in
Figure 1D and applied to the flow cytometer. FAVS analysis re-
vealed that 99% of all DAPI-labeled particles are associated
with some level of IAP signal (P4, Figure 1E). Double-positive
particles were further analyzed to select for populations with
low (P5, Figure 1F) and high (P6, Figure 1F) levels of IAP enrich-
ment. Imaging of postsort ‘‘P6’’ material revealed numerous
examples of rod-shaped bacteria surrounded by IAP-enriched
puncta (Figure 1G). Thus, the LV/microbe complexes observed
Figure 1. LVs Dephosphorylate LPS and Interact with Native Lumenal
Bacteria
(A) LVs release phosphate from E. coli O55:B5 LPS in a concentration-
dependent manner; phosphate release is reduced by the IAP competitive
inhibitor L-phenylalanine (L-Phe).
(B) LVs (200 mg LVs/ml) and purified IAP (2 U/ml) differentially dephosphor-
ylate LPS derived from various Gram-negative bacterial species. Data
represent mean 6 SEM.
(C) TEM imaging reveals vesicle-like particles in close association with
native lumenal bacteria from rat LV preparations. Scale bar represents
200 nm.
(D) CM imaging reveals IAP enrichment (green) on membranes (red) associ-
ated with DAPI-stained bacteria (blue). Scale bars represent 2 mm.
(E) Presort input material was analyzed for staining with both anti-IAP (LVs)
and DAPI (bacteria) using the P4 gate.
(F) P4 material was sorted using gates for IAP (P5, low IAP enrichment) and
dual stained material (P6, high IAP enrichment).
(G) CM images of sorted P6 material show native LV/microbe complexes
(green = IAP, blue = DAPI). Scale bar represents 2 mm.
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aremost likely formed in the lumen and not as a result of centri-
fugation or other processing.
LVs Prevent EPEC Adherence to IECs
Because LVs bind directly to lumenal bacteria, microvillar
vesicle shedding could serve as a host defense mechanism
capable of preventing the adherence of pathogenic bacteria
that target the IEC apical surface. To test this idea, we
sought to determine whether LVs impacted the ability ofenteropathogenic E. coli (EPEC, strain E2348/69) to infect
human IECs (HT-29 and CACO-2BBE cells) in culture. EPEC
uses a type III secretion system to inject factors into host cells
that lead to microvillar effacement, which in turn enables inti-
mate adhesion to the apical surface, an event essential for
EPEC pathogenesis [14]. We incubated confluent monolayers
of HT-29 cells withw13 105 colony-forming units (cfu) EPEC/
ml media in the presence or absence of 200 mg LVs/ml media
(see Supplemental Experimental Procedures). After a 3 hr
incubation, monolayers were stained and then imaged using
CM (Figures 2A and 2B) or scanning electron microscopy
(SEM, Figures 2C and 2D). Consistent with a previous report
[15], we found that IAP was enriched on the surface of bacteria
bound to the cell monolayer, independent of the presence of
actin pedestals (arrowheads, Figures 2A and 2B). Confocal
images were further analyzed by counting (1) the number of
EPEC organisms bound per unit area, independent of stage
of attachment (Figure 2E), and (2) the number of microcolonies
per unit area (Figure 2F) [16]. Both indices showed that LVs
significantly reduced EPEC attachment to HT-29 monolayers
(Figures 2E and 2F). Similar results were observed when
experiments were carried out with CACO-2BBE cells (data not
shown). SEM on CACO-2BBE cultures confirmed that EPEC
actin pedestal formation was reduced in the presence of LVs
(Figures 2C and 2D). Neither fixing LVs nor inhibiting LV-asso-
ciated IAP activity with L-Phe impacted the ability of vesicles
to limit EPEC attachment to HT-29 cells (Figures 2E and 2F).
Finally, purified IAP had little impact on the number of bacteria
bound to themonolayer surface (Figures 2E and 2F). Thus, LVs
prevent EPEC from intimately attaching to IECs in culture via
a mechanism that does not depend on IAP catalytic activity.
Bacteria and bacterial products activate proinflammatory
NF-kB signaling [17]. Thus, we sought to determine whether
LVs were capable of preventing activation of NF-kB signaling
in response to EPEC. A hallmark of NF-kB pathway activation
is translocation of the transcription factor RelA into the
nucleus [4]. We transfected HT-29 cells with EGFP-tagged
human RelA [18], incubated cells in serum free media for
3 hr, and then scored the fraction of transfected cells with
nuclear RelA. Under these conditions, 14% of cells expressing
the construct demonstrated RelA in the nucleus (Figure 2G). In
cells treated with EPEC, nuclear localization of RelA is
observed in 31% of expressing cells, compared with 21% in
EPEC-exposed cells treated simultaneously with 200 mg LVs/
ml (Figure 2G). The attenuated response observed here is likely
due to the fact that IECs limit expression of cell-surface recep-
tors such as TLR4, to prevent constitutive proinflammatory
signaling [19]. Together these data indicate that LVs inhibit
interactions between adherent pathogenic bacteria and IECs
and limit the downstream NF-kB signaling that would other-
wise be triggered by these interactions.
LVs Limit Bacterial Population Growth
Direct association with microbes might also enable LVs to
impact bacterial viability. To investigate this possibility, we
treated liquid cultures withw2.53 104 cfu EPEC/ml with either
0 or 50 mg LVs/ml and incubated overnight; OD600 was
measured at 10 min intervals. Although addition of LVs did
not prevent initiation of log growth in EPEC (t = 428 hr), the
maximum OD600 achieved in the presence of LVs was signifi-
cantly reduced (Figure 3A, black lines). We carried out similar
growth assays with bacterial isolates derived from native
lumenal material using MacConkey selection [20]. As with
EPEC, native isolates entered log phase approximately 4 hr
Figure 2. LVs Prevent EPEC Attachment to IECs
(A and B) CM images of HT-29monolayers treated with EPEC6 LVs stained for IAP (green), F-actin (phalloidin, red), and bacteria (DAPI, blue), show striking
enrichment of IAP surrounding attached bacteria. Most EPEC in non-LV treated samples (A) form microcolonies and are associated with actin pedestals
(arrows), indicating intimate attachment, whereas this rarely occurs in the presence of LVs (B). Arrowheads in (A) and (B) denote examples of EPEC super-
ficially attached to the monolayer, indicated by the absence of pedestal formation. Scale bars represent 5 mm.
(C and D) Representative SEM images of CACO-2BBE cells demonstrate EPEC intimately associated with the cell surface in the absence (C), but not the
presence of LVs (D). Scale bars represent 1.67 mm.
(E) The number of EPEC attached to HT-29 cells is significantly reduced in the presence of LVs, LVs fixed in paraformaldehyde, and LVs with IAP activity
inhibited by L-Phe, but not in the presence of purified IAP (*p < 0.05). Error bars represent SEM.
(F) LVs also reduce the number of microcolonies formed. Error bars represent SEM.
(G) Nuclear translocation of EGFP-RelA is increased in HT-29 cells incubated with EPEC, an effect that is partially ameliorated by treatment with LVs.
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629into the assay, but inclusion of 50 mg LVs/ml reduced the
maximum OD600 (Figure 3A, red and blue lines). 16S ribosomal
subunit DNA sequence analysis showed that both commen-
sals used in this assay were members of the genus
Escherichia, most likely E. coli (data not shown). Further exper-
imentation revealed that the impact of LVs on bacterial popu-
lation growth is not mediated by IAP or its catalytic activity(C) LVs reduce the number of viable bacteria (cfu), as sampled at the en
stationary cultures incubated for 16 hr. *p < 0.05 versus untreated. Error bars(Text S1; Figure S2A). Moreover, LVs were not reducing the
concentration of nutrients available to growing bacteria or
otherwise conditioning the culture environment (Text 1; Fig-
ure S2B). Adding LVs to stationary phase EPEC cultures also
led to a striking decline in OD600 over a similar 16 hr time
course (Figure 3B, orange lines). Comparable results were
obtained with stationary EPEC cultures that were firstFigure 3. LVs Inhibit Bacterial Population Growth
(A) Incubating both EPEC and native intestinal
bacterial cultures with 50 mg LVs/ml reduces
OD600 achieved at stationary phase (t = 8–16 hr)
following log growth (t = 4–8 hr). Black lines
represent EPEC, blue and red lines represent
native E. coli.
(B) Stationary phase EPEC cultures incubated
with LVs show a reduction in OD600 compared
to untreated samples over the course of 16 hr,
both in cultures with nutrient-depleted media
(orange lines) or fresh media (dark red lines).
Traces represent averaged recordings from
multiple experiments (n = 3–8).
d of cultures started with 2.5 3 104 cfu/ml and incubated for 16 hr or
represent SEM.
Figure 4. EPEC Stimulates LV Release from IECs
(A) LVs accumulate in CACO-2BBE cell culture
media over time. Media was subject to ultra-
speed centrifugation and 100,000 3 g pellets
were processed for western blotting with probes
for IAP and annexin A13b; whole cell homoge-
nates (WCH) from each time point were pro-
cessed in parallel and probed for actin.
(B) Whole-cell IAP expression levels increase
upon exposure to EPEC.
(C) EPEC stimulates increased LV production
from CACO-2BBE cells, indicated by the presence
of IAP in the LV-containing 100,0003 g pellet fraction. EPEC-stimulated LV production is attenuated by expression of aMyo1a dominant-negative construct
(TH1 DN). Shedding requires intact, live bacteria, because EPEC-conditioned media, heat-killed EPEC, and purified LPS fail to stimulate LV production.
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lines). Finally, cfu analysis of culture end points revealed that
LVs most likely reduce OD600 values by accelerating bacterial
death (Text S2; Figure 3C). Together, these results indicate
that LVs limit the population density of commensal and patho-
genic E. coli in amanner independent of the catalytic activity of
IAP or other enzymes.
EPEC Stimulates LV Production
All of our assays with native LVs isolated from rodent small
intestine (Figures 1, 2, and 3) indicate that LVs likely function
as a host defense platform. Because many host defense path-
ways and processes are regulated by bacterial toxins or intact
bacteria [21, 22], we sought to determine whether LV produc-
tion was controlled in a similar manner. For these experiments,
we developed a culture model of microvillar vesicle shedding
using CACO-2BBE cells [23–25]. CACO-2BBE cells polarize,
form a well-ordered brush border, and demonstrate robust
microvillar vesicle shedding similar to native IECs, as indicated
by the accumulation of small vesicles (Figure S3A) containing
LV markers, IAP and annexin A13b [7], in culture media
(Figure 4A). When CACO-2BBE cells were exposed to w1 3
106 cfu EPEC/ml for 6 hr, total cellular levels of IAP increased
dramatically (Figure 4B), consistent with previous work in
zebrafish [26]. EPEC exposure also significantly increased
the amount of IAP-enriched LVs released into culture media
(Figure 4C). Accumulation of IAP in the 100,0003 g pellet likely
represents bona fide vesicle shedding, rather than microvillar
fragmentation, because no actin is observed in these fractions
(Figure 4C). Additionally, CACO-2BBE cells expressing the
Myo1a-TH1 domain (TH1 DN), which acts as a dominant nega-
tive inhibiting the function of endogenous Myo1a [27], do not
release IAP-enriched vesicles into culture media (Figure 4C).
We also found that vesicle shedding was stimulated, albeit
to a lesser extent, by Shigella, another Gram-negative enteric
pathogen (Figure S3B) [28]. However, vesicle shedding was
not stimulated by EPEC-conditioned media [29], heat-killed
EPEC, or 10 mg/ml E. coli O55:B5 LPS (Figure 4C). These find-
ings indicate thatmicrovillar vesicle shedding is upregulated in
response to EPEC exposure, and that this response requires
live, intact bacteria.
Conclusions
Previous work investigating the physiological function of IAP
has focused on the activity of this enzyme as a soluble or
cell-associated host defense factor in the gut lumen [2–5, 30].
The findings reported here suggest that microvillar vesicle
shedding is a mechanism for distributing IAP activity into the
mucous layer or gut lumen. Deploying IAP in this manner
would enable chemical modification of bacterial toxins (i.e.,dephosphorylation of LPS; Figures 1A and 1B; Figure S1) at
sites distal to the apical surface of IECs. However, LVs also
limit the attachment of pathogenic bacteria to IECs and inhibit
bacterial population growth (Figures 2 and 3; Figure S2). More-
over, IAP expression and LV production are upregulated by
pathogenic Gram-negative bacteria (Figure 4; Figure S3).
Based on these data and the fact that trillions of microvilli
extend from the surface of IECs, we propose that microvillar
vesicle shedding represents a powerful mechanism for limiting
the potentially harmful impact of microbes and associated
proinflammatory compounds that accumulate in the intestinal
lumen. Future studiesmust focus on definingmechanisms that
regulate LV production in response tomicrobial signals, mech-
anisms responsible for the impact of LVs on bacterial viability,
and the role of LV production in animal models of gut disease.
Supplemental Information
Supplemental Information includes three figures, two texts, and Supple-
mental Experimental Procedures and can be found with this article online
at doi:10.1016/j.cub.2012.02.022.
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